$28.81
0.792.82%
Last update: Nov 5, 10:06 AM
Amphastar Pharmaceuticals Inc
AMPHNASDAQ
The average analyst price target for Amphastar Pharma is $28.13, 2.4% below the current price. Of 5 analysts, 4 rate it Hold and 1 Sell. Targets range from $20 to $55. The latest change came on Aug 18, 2026, when Barclays raised its price target on Amphastar Pharma from $20 to $23 and kept an Equal-Weight rating.
Price Target Range — 12 Quarters
Analyst Consensus — 5 Analysts
Rating Trend — Last 9 Months
